DALFAMPRIDINE (dalfampridine) by Teva is elucidated. Approved for walking in adult patients with multiple sclerosis (ms), multiple sclerosis.
Drug data last refreshed 1mo ago
elucidated. Dalfampridine is a broad spectrum potassium channel blocker. In animal studies, dalfampridine has been shown to increase conduction of action potentials in demyelinated axons through inhibition of potassium channels.
Worked on DALFAMPRIDINE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Dalfampridine for Imbalance in Multiple Sclerosis